Impella devices have been the subjects of a series of Abiomed letters and FDA early alerts and recall notices. In January, Abiomed sent an urgent medical device correction about a malfunction risk ...
Johnson & Johnson subsidiary Abiomed recalled its Impella left sided blood pumps for risk that the devices could perforate the heart during a procedure. The recall began on Dec. 27 with Abiomed ...
More Impella left-sided blood pumps are under Class I recall, this time for potential interactions with transcatheter aortic valve replacement (TAVR) stents, the FDA announced Thursday. The affected ...
Johnson & Johnson’s Abiomed division is once again the subject of a Class I recall for its Impella heart pumps, this time pertaining to a potential safety conflict in patients with transcatheter ...
A pricey high-tech pump that maintains blood flow during heart procedures could be more dangerous to patients than its low-tech predecessor, a pair of recent studies finds. The Impella device is ...
Despite a lack of large randomized trials clarifying when and in whom it might work best, use of Impella (Abiomed) for mechanical circulatory support in patients with acute MI complicated by ...
Abiomed's Impella heart pumps are carving out an important niche in cardiac cath labs. With the S&P Healthcare Equipment Select Industry Index up 32% this past year, it's clear that the industry ...
ABIOMED Inc. ( ABMD) revealed that it has acquired Berlin, Germany-based medical device maker Entwicklungsgesellschaft mbH or ECP. The acquisition is in line with its strategy to provide percutaneous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results